Literature DB >> 1773957

Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation.

P Gibson1, M Lichtenstein, N Salehi, G Hebbard, J Andrews.   

Abstract

The value of positive scans of autologous 99mTc-labelled leucocytes in the detection of intestinal inflammation was assessed in 29 patients with known inflammatory bowel disease and a high probability of intestinal inflammation and 58 with a low probability of intestinal inflammation comprising 37 with intestinal symptoms and 21 with suspected abscess. Autologous leucocytes were labelled with 99mTc using either of the established methods. In patients with inflammatory bowel disease, 3/13 with ileocaecal and 1/11 with colonic accumulation of 99mTc were incorrectly diagnosed in that there was no histological evidence of inflammation in those regions. In the low probability patients, all 26 positive images were false positives: there were 19 in the ileocaecal and 7 in colonic regions and no differences between the two subgroups. False positives were more common in low probability than high probability patients (p = 0.011). The results were independent of the 99mTc cell labelling technique used. Three false positive patients also had normal scans for 111In-labelled granulocytes. The time of first detection of 99mTc in the bowel was earlier in true than in false positive patients (92% v 33% within 1 h, p = 0.008), the false positive rates in the first hour of imaging being 5% in high and 15% in low probability patients. In 99mTc scintigraphy, the appearance of the isotope in the intestine occurs commonly in the absence of inflammation irrespective of the cell labelling technique used. In high probability patients, imaging at 1 h can more reliably discriminate true from false positives and retain clinical usefulness. In low probability patients specificity remains unacceptable and 99mTc-labelled leucocyte scanning in these patients is of little value as a positive predictor of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773957      PMCID: PMC1379251          DOI: 10.1136/gut.32.12.1502

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

Review 1.  Imaging with white cells.

Authors:  A M Peters
Journal:  Clin Radiol       Date:  1989-09       Impact factor: 2.350

2.  Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning.

Authors:  W E Pullman; P J Sullivan; P J Barratt; J Lising; J A Booth; W F Doe
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

3.  Early and delayed indium 111 leukocyte imaging in Crohn's disease.

Authors:  F Navab; C M Boyd; W C Diner; R Subramani; C Chan
Journal:  Gastroenterology       Date:  1987-10       Impact factor: 22.682

4.  Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.

Authors:  M E Roddie; A M Peters; H J Danpure; S Osman; B L Henderson; J P Lavender; M J Carroll; R D Neirinckx; J D Kelly
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

5.  Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?

Authors:  P R Gibson; E van de Pol; P J Barratt; W F Doe
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

6.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

7.  99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.

Authors:  A M Peters; M E Roddie; H J Danpure; S Osman; G P Zacharopoulos; P George; A W Stuttle; J P Lavender
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

8.  White cells radiolabelled with 111In and 99Tcm--a study of relative sensitivity and in vivo viability.

Authors:  D C Costa; D Lui; P J Ell
Journal:  Nucl Med Commun       Date:  1988-10       Impact factor: 1.690

9.  Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.

Authors:  S H Saverymuttu; M Camilleri; H Rees; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

10.  111Indium autologous granulocytes in the detection of inflammatory bowel disease.

Authors:  S H Saverymuttu; A M Peters; M E Crofton; H Rees; J P Lavender; H J Hodgson; V S Chadwick
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

View more
  13 in total

1.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

2.  Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease.

Authors:  M Papós; F Nagy; J Láng; L Csernay
Journal:  Eur J Nucl Med       Date:  1993-09

3.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Authors:  M H Giaffer
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

4.  Quantification of inflammatory bowel disease activity using technetium-99m HMPAO labelled leucocyte single photon emission computerised tomography (SPECT).

Authors:  M J Weldon; A M Masoomi; A J Britten; J Gane; C J Finlayson; A E Joseph; J D Maxwell
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

5.  Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease.

Authors:  M Sans; D Fuster; J Llach; F Lomeña; J M Bordas; R Herranz; J M Piqué; J Panés
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

6.  Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings.

Authors:  J J Kolkman; T H Falke; J C Roos; D H Van Dijk; I M Bannink; W Den Hollander; M A Cuesta; A S Peña; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

7.  99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn's disease.

Authors:  L Biancone; F Scopinaro; M Ierardi; P Paoluzi; A Marcheggiano; M C Di Paolo; B Porowska; A C Colella; F Pallone
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

8.  Indium scanning in assessment of acute Crohn's disease. A prospective study of sensitivity and correlation with severity of mucosal damage.

Authors:  D Heresbach; J F Bretagne; J L Raoul; A Moisan; L Siproudhis; A Devillers; M Gosselin
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

9.  Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies.

Authors:  S Almers; G Granerus; L Franzén; M Ström
Journal:  Eur J Nucl Med       Date:  1996-03

10.  Anti-granulocyte immunoscintigraphy and [99mTc]hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease.

Authors:  M Papos; F Nagy; G Narai; M Rajtar; G Szantai; J Lang; L Csernay
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.